StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)

Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –

Incyte total assets

Total assets on the balance sheet at the end of each period.

Incyte's total assets was $7.29B at Sep 30, 2026. For fiscal 2025 it was $6.96B, up 27.8% from the year before. Over ten years it grew 21.3% a year on average. The highest annual figure on record is $6.96B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.96B+27.8%
FY2024Dec 31, 2024$5.44B-19.7%
FY2023Dec 31, 2023$6.78B+16.1%
FY2022Dec 31, 2022$5.84B+18.4%
FY2021Dec 31, 2021$4.93B+38.5%
FY2020Dec 31, 2020$3.56B+3.9%
FY2019Dec 31, 2019$3.43B+29.5%
FY2018Dec 31, 2018$2.65B+14.9%
FY2017Dec 31, 2017$2.30B+40.5%
FY2016Dec 31, 2016$1.64B+62.6%
FY2015Dec 31, 2015$1.01B+26.5%
FY2014Dec 31, 2014$796.48M+26.5%
FY2013Dec 31, 2013$629.57M+90.5%
FY2012Dec 31, 2012$330.42M+0.4%
FY2011Dec 31, 2011$328.96M-32.8%
FY2010Dec 31, 2010$489.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$7.29B+15.1%
Q2 FY2026Jun 30, 2026$7.87B+35.2%
Q1 FY2026Mar 31, 2026$7.34B+27.7%
Q4 FY2025Dec 31, 2025$6.96B+27.8%
Q3 FY2025Sep 30, 2025$6.33B+26.3%
Q2 FY2025Jun 30, 2025$5.82B+24.9%
Q1 FY2025Mar 31, 2025$5.75B-19.4%
Q4 FY2024Dec 31, 2024$5.44B-19.7%
Q3 FY2024Sep 30, 2024$5.01B-21.5%
Q2 FY2024Jun 30, 2024$4.66B-24.9%
Q1 FY2024Mar 31, 2024$7.14B+23.1%
Q4 FY2023Dec 31, 2023$6.78B+16.1%
Q3 FY2023Sep 30, 2023$6.39B+15.9%
Q2 FY2023Jun 30, 2023$6.21B+16.7%
Q1 FY2023Mar 31, 2023$5.80B+14.7%
Q4 FY2022Dec 31, 2022$5.84B+18.4%
Q3 FY2022Sep 30, 2022$5.51B+31.2%
Q2 FY2022Jun 30, 2022$5.32B+36.2%
Q1 FY2022Mar 31, 2022$5.05B+38.0%
Q4 FY2021Dec 31, 2021$4.93B+38.5%
Q3 FY2021Sep 30, 2021$4.20B+27.0%
Q2 FY2021Jun 30, 2021$3.90B+21.6%
Q1 FY2021Mar 31, 2021$3.66B+33.0%
Q4 FY2020Dec 31, 2020$3.56B+3.9%
Q3 FY2020Sep 30, 2020$3.31B+2.9%
Q2 FY2020Jun 30, 2020$3.21B+9.0%
Q1 FY2020Mar 31, 2020$2.75B-0.1%
Q4 FY2019Dec 31, 2019$3.43B+29.5%
Q3 FY2019Sep 30, 2019$3.21B+27.6%
Q2 FY2019Jun 30, 2019$2.95B+23.0%
Q1 FY2019Mar 31, 2019$2.75B+19.4%
Q4 FY2018Dec 31, 2018$2.65B+14.9%
Q3 FY2018Sep 30, 2018$2.52B+6.1%
Q2 FY2018Jun 30, 2018$2.40B+46.2%
Q1 FY2018Mar 31, 2018$2.31B+43.5%
Q4 FY2017Dec 31, 2017$2.30B+40.5%
Q3 FY2017Sep 30, 2017$2.37B–
Q2 FY2017Jun 30, 2017$1.64B–
Q1 FY2017Mar 31, 2017$1.61B–
Q4 FY2016Dec 31, 2016$1.64B–

More Incyte figures

See a number that looks wrong?